[Federal Register Volume 73, Number 235 (Friday, December 5, 2008)]
[Notices]
[Page 74195]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E8-28748]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Application

    Pursuant to 21 U.S.C. 958(i), the Attorney General shall, prior to 
issuing a registration under this section to a bulk manufacturer of a 
controlled substance in schedule I or II, and prior to issuing a 
registration under 21 U.S.C. 952(a)(2) authorizing the importation of 
such a substance, provide manufacturers holding registrations for the 
bulk manufacture of the substance an opportunity for a hearing.
    Therefore, in accordance with Title 21 Code of Federal Regulations 
(CFR), 1301.34(a), this is notice that on October 6, 2008, Tocris 
Cookson, Inc., 16144 Westwoods Business Park, Ellisville, Missouri 
63021-4500, made application by renewal to the Drug Enforcement 
Administration (DEA) for registration as an importer of the basic 
classes of controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Marihuana (7360)............................  I
Tetrahydrocannabinols (7370)................  I
Amphetamine (1100)..........................  II
Phencyclidine (7471)........................  II
Cocaine (9041)..............................  II
Diprenorphine (9058)........................  II
------------------------------------------------------------------------

    The company plans to import the above listed controlled substances 
for non-clinical laboratory based research only.
    Any bulk manufacturer who is presently, or is applying to be, 
registered with DEA to manufacture such basic classes of controlled 
substances may file comments or objections to the issuance of the 
proposed registration and may, at the same time, file a written request 
for a hearing on such application pursuant to 21 CFR 1301.43 and in 
such form as prescribed by 21 CFR 1316.47.
    Any such comments or objections being sent via regular mail should 
be addressed, in quintuplicate, to the Drug Enforcement Administration, 
Office of Diversion Control, Federal Register Representative (ODL), 
8701 Morrissette Drive, Springfield, Virginia 22152; and must be filed 
no later than January 5, 2009.
    This procedure is to be conducted simultaneously with and 
independent of the procedures described in 21 CFR 1301.34(b), (c), (d), 
(e), and (f). As noted in a previous notice published in the Federal 
Register on September 23, 1975, (40 FR 43745-46), all applicants for 
registration to import basic classes of any controlled substances in 
schedules I or II are, and will continue to be, required to demonstrate 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, that the requirements for such 
registration pursuant to 21 U.S.C. 958(a); 21 U.S.C. 823(a); and 21 CFR 
1301.34(b),(c),(d),(e), and (f) are satisfied.

    Dated: November 26, 2008.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
 [FR Doc. E8-28748 Filed 12-4-08; 8:45 am]
BILLING CODE 4410-09-P